REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
03/21/2026
Back to search
Official data from USPTO
SEQIRUS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
SEQIRUS
ST13
US500000086726994Class
1, 5, 44
Filing
86726994
Registration
5163878
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
44
Latest update
03/22/2026
Trademark type
Word
Nice classes
1, 5, 44
Filing date
08/17/2015
Registration date
03/21/2017
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/15/2024
Last transaction
03/22/2026
Responsible office
United States Patent and Trademark Office
Status code
705
Official register
Principal Register
Filing basis
Intent to use, Foreign priority
Drawing code
4
Owner type
99
Owner location
Berkshire, GB
Examiner
SNABB, SANDRA MARIE
Law office
N20
Holders and representatives
Holders
Seqirus UK Limited
Seqirus UK Limited
Representatives
Nancy Sabarra Fross Zelnick Lehrman & Zissu, P.C.
Technical classification
Nice Classes
Class 1Class 5Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Chemical and biological reagents for scientific and non-medical purposes; cell cultures and media for laboratoryscientific and research use; test kits for scientific and non-medical laboratory use for anti-body screeningblood grouping or detection of specific blood cellsantigens and immunoglobulin subtypes; chemical preparations for scientific and industrial purposes; diagnostic and testing agents for scientific and non-medical purposes; Chemical and biological reagents for non-medical purposes; chemical and biological reagents for industrial use for anti-body screeningblood groupingfor the typing and detection of specific blood cellsdetermining the presence of antigens on blood cellsthe detection of relevant complement compounds and immunoglobulin subtypes; chemical test kits for the detection of specific blood cellsdetermining the presence of antigens on blood cellsthe detection of relevant complement compounds and immunoglobulin subtypes for laboratory or research use; chemical preparations for industrial use for anti-body screeningblood groupingthe typing and detection of specific blood cells
Class 5
Pharmaceutical preparations and substances for the treatment and prevention of blood disordersbleeding disordersdiseases caused by bacteria and viruses; vaccines; blood productsimmunoglobulins for medical or clinical use; medicated serums for the treatment of influenza; anti-virals; influenza vaccines; adjuvants and antigens for medical purposes; blood productsblood plasmareagent blood cells; products derived from blood and products derived from recombinant DNA technologyimmunoglobulinshuman albuminblood clotting factorsplasma volume expandersblood proteins for therapeutic use; serumsanti-venoms; medicated serums for the treatment of blood disorders and bleeding disorders; test kitsinvitro diagnostic reagent test kits for use in detecting cell mediated immune response; pharmaceutical preparations and substancesRheysys Factor D Antigen reagents for the detection of specific antigens or in blood typing; pharmaceutical preparationsreagent red blood cells used to detect antibodies and Immunoglobulin subtypes; pharmaceutical preparationstherapeutic monoclonal and polyclonal antibodies and antibodies for use in the treatment of infectious diseases ; pharmaceutical preparationsreagents for medical and clinical use for the typing and detection of specific blood cellsthe detection of relevant compliment components and immunoglobulin subtypes
Class 44
Medical services; medical information services; health care services; health care information servicesinternet-based health care information services; providing medical information concerning blood products; providing medical information concerning vaccinesanti-venoms and immunohematology productsdiagnostic reagents; patient support servicesproviding an Internet-based database of patient medical informationwhere patients can enquire about medical issues and procedures from other patients and can relay information about their medical experiences for support and community
Publications
History of USPTO decisions and trademark events.
44 publications found
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
03/15/2024
C15P
REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
03/15/2024
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
03/15/2024
E815
TEAS SECTION 8 & 15 RECEIVED
09/21/2023
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
03/21/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
11/25/2019
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
11/25/2019
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
12/18/2018
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
12/18/2018
R.PR
REGISTERED-PRINCIPAL REGISTER
03/21/2017
DP1B
1(B) BASIS DELETED; PROCEED TO REGISTRATION
02/14/2017
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
01/21/2017
IUCN
NOTICE OF ALLOWANCE CANCELLED
01/05/2017
D1BR
TEAS DELETE 1(B) BASIS RECEIVED
01/05/2017
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
12/13/2016
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10/18/2016
PUBO
PUBLISHED FOR OPPOSITION
10/18/2016
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
09/28/2016
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
09/13/2016
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/08/2016
XAEC
EXAMINER'S AMENDMENT ENTERED
09/07/2016
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
09/07/2016
GNEA
EXAMINERS AMENDMENT E-MAILED
09/07/2016
CNEA
EXAMINERS AMENDMENT -WRITTEN
09/07/2016
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/01/2016
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/01/2016
ALIE
ASSIGNED TO LIE
08/25/2016
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/18/2016
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
07/01/2016
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
07/01/2016
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
06/24/2016
GNRT
NON-FINAL ACTION E-MAILED
06/24/2016
CNRT
NON-FINAL ACTION WRITTEN
06/24/2016
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/03/2016
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/02/2016
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/02/2016
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
06/02/2016
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
12/03/2015
GNRT
NON-FINAL ACTION E-MAILED
12/03/2015
CNRT
NON-FINAL ACTION WRITTEN
12/03/2015
DOCK
ASSIGNED TO EXAMINER
12/01/2015
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/20/2015
NWAP
NEW APPLICATION ENTERED
08/20/2015
Continuous trademark protection
Get notified about every new filing that threatens SEQIRUS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.